Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Global Health Network and the Family Larsson Rosenquist Foundation (FLRF) launch LactaHub: an open access knowledge platform featuring scientific and evidence-based information on breastfeeding and breastmilk for health professionals

Logos: TGHN and the Family Larsson Rosenquist Foundation

The Global Health Network and FLRF have created LactaHub to enable health professionals, decision-makers and researchers to be more effective in their daily work.

LactaHub is where scientific and evidence-based knowledge about breastfeeding and breastmilk will be brought together in a structured, practice-oriented manner. All content will be reviewed and verified for quality by an independent scientific editorial board, and made freely available.

LactaHub aims to become a thriving community of practice in the field of breastfeeding by:

  • Ensuring equal access to the best guidance and knowledge available, in one central location
  • Simplifying the search for objective information that has been independently verified
  • Opening new channels for knowledge transfer among health professionals – without physical or financial borders

Are you working in healthcare, policy or research with an interest in breastfeeding and the first 1,000 days? Learn more and please join the community

About The Global Health Network, of the University of Oxford

Faster and better research is critical to solving the world’s biggest health challenges. The Global Health Network enables researchers and organisations to share best practice and know-how with each other to drive progress, while empowering local health professionals undertaking research in the world’s most vulnerable settings. The Global Health Network facilitates sustainable health improvements through sharing of research methods, delivering training and supporting career development. The result is easier, faster, better research to help address the world's biggest health challenges.

About the Family Larsson Rosenquist Foundation

The Family Larsson-Rosenquist Foundation was established in 2013, born from the vision of a world in which every child is granted an optimum start in life through the benefits of breastmilk. Based in Frauenfeld, Switzerland, it is one of the world’s only philanthropic foundations dedicated entirely to supporting and promoting breastfeeding and breastmilk.

 

 

Similar stories

RECOVERY Trial announced as overall winner of Best COVID-19 Response Project Award in the UK

The RECOVERY Trial has won the Project Management Institute’s Special Covid-19 UK Response Project Award. The award specifically recognised RECOVERY’s work to investigate whether the cheap steroid dexamethasone was an effective treatment for patients hospitalised with severe COVID-19.

ISARIC COVID-19 clinical database passes ½ million patient records mark

COVID-19 has exposed our vulnerability to pandemic infections and shown what works, and what does not. It has tested the effectiveness of the Oxford-based global, open-source, collaborative approach set up 10 years ago to prevent illness and deaths from infectious disease outbreaks: ISARIC, the International Severe Acute Respiratory and Emerging Infection Consortium.

RECOVERY Trial named joint winner of HDR UK’s Impact of the Year Award

The RECOVERY trial has been jointly awarded Health Data Research UK’s 2021 Impact of the Year Award. This award is open to projects which had effectively used health data to improve people’s lives, including through clinical practice, policy, software, algorithms, or publications. The award was presented by James O’Shaughnessy at HDR UK’s online Annual Scientific Conference: Data Insights in a Pandemic.

OUCRU scientists identify combination of biological markers associated with severe dengue

Nguyen Lam Vuong, Sophie Yacoub & colleagues have identified a combination of biological markers in patients with dengue that could predict whether they go on to develop moderate to severe disease. Biomarkers are used to identify the state or risk of a disease in patients; these findings could aid the development of biomarker panels for clinical use and help improve triage and risk prediction in patients with dengue.

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

RECOVERY trial finds Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients who have not mounted their own immune response

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.